Page 1

MEDIOS Press Release Medios AG starts the 2021 financial year with a record quarter • Group sales and earnings nearly doubled in Q1 2021 • • First - time consolidation of Cranach Pharma GmbH Outlook 2021 : Almost doubling of group sales and significant increase in earnings Berlin , 11 May 2021 - Medios AG ( " Medios " ) , the leading provider of Specialty Pharma Solutions in Germany , confirms its forecast for the 2021 financial year after a successful first quarter . Group sales in the period from January to March 2021 increased by 94.0 % to € 315.9 million compared to the same period of the previous year ( € 162.8 million ) . EBITDA pre¹ increased by 106.5 % to € 8.8 million ( previous year € 4.3 million ) . EBT pre¹ climbed by 90.7 % to € 7.1 million ( previous year € 3.7 million ) . Thus , both group sales and earnings reached new record levels . Both operating segments contributed to the growth in group sales as well as earnings with improved operating margins . The specialized pharmaceutical wholesaler Cranach Pharma GmbH , acquired in January 2021 , contributed to Medios ' growth in the first quarter of 2021 with a revenue of € 139.6 million and EBITDA pre¹ of € 5.0 million . Matthias Gaertner , CEO and CFO of Medios AG : “ With the acquisition of Cranach Pharma GmbH , we are the leading Specialty Pharma provider in Germany - which is reflected in our best quarterly result to date . Due to the increase in profit margins in both segments , we could achieve a clearly positive operating cash flow . We also advanced our ESG activities by joining the United Nations Global Compact . In the coming months , we will continue to focus on acquisitions and sustainability alongside organic growth . “ The latest acquisitions have increased Medios ' partner network to around 500 specialized pharmacies . The United Nations Global Compact is the world's largest initiative for responsible corporate leadership . By joining in the first quarter of 2021 , Medios has committed to upholding the network's ten universal principles and sustainability goals . Medios ' aim is to adopt a comprehensive ESG strategy in the 2021 financial year . The company's ESG activities are explained for the first time in a voluntary Nonfinancial Group Statement in the Annual Report 2020 . With the innovative mediosconnect software platform , the company is already well prepared for the introduction of the legally required e - prescription on January 1 , 2022 . This digital platform for complex and individualized medicines connects doctors ,